Cargando…
Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
BACKGROUND: The aim of this study is to evaluate the retention rates and reasons for discontinuation for seven biological disease-modifying antirheumatic drugs (bDMARDs) in a real-world setting of patients with rheumatoid arthritis (RA). METHODS: This multi-center, retrospective study assessed 4466...
Autores principales: | Ebina, Kosuke, Hashimoto, Motomu, Yamamoto, Wataru, Hirano, Toru, Hara, Ryota, Katayama, Masaki, Onishi, Akira, Nagai, Koji, Son, Yonsu, Amuro, Hideki, Yamamoto, Keiichi, Maeda, Yuichi, Murata, Koichi, Jinno, Sadao, Takeuchi, Tohru, Hirao, Makoto, Kumanogoh, Atsushi, Yoshikawa, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458752/ https://www.ncbi.nlm.nih.gov/pubmed/30971306 http://dx.doi.org/10.1186/s13075-019-1880-4 |
Ejemplares similares
-
Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
por: Ebina, Kosuke, et al.
Publicado: (2019) -
Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-
por: Ebina, Kosuke, et al.
Publicado: (2019) -
Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-
por: Ebina, Kosuke, et al.
Publicado: (2018) -
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study
por: Jinno, Sadao, et al.
Publicado: (2021) -
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
por: Ebina, Kosuke, et al.
Publicado: (2022)